Published in J Toxicol Clin Toxicol on January 01, 1998
A mechanism of paraquat toxicity involving nitric oxide synthase. Proc Natl Acad Sci U S A (1999) 1.38
Mechanism of cytotoxicity of paraquat. Environ Health Prev Med (2002) 0.95
Delayed immunosuppressive treatment in life-threatening paraquat ingestion: a case report. J Med Toxicol (2009) 0.86
Nitric oxide inhalation for paraquat--surviving both poisoning and therapy? J Toxicol Clin Toxicol (1998) 0.75
Hepatocyte proliferation in vitro: its dependence on the use of serum-free hormonally defined medium and substrata of extracellular matrix. Proc Natl Acad Sci U S A (1984) 2.64
The role of chest and abdominal computed tomography in assessing the severity of acute corrosive ingestion. Clin Toxicol (Phila) (2013) 2.06
Atropine poisoning in children during the Persian Gulf crisis. A national survey in Israel. JAMA (1992) 1.62
Acute changes in renal function associated with deferoxamine therapy. Am J Dis Child (1989) 1.59
Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone. J Allergy Clin Immunol (1998) 1.59
Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients. Pediatr Transplant (2001) 1.53
Menstrual asthma: use of a gonadotropin-releasing hormone analogue for the treatment of cyclic aggravation of bronchial asthma. Fertil Steril (1994) 1.43
Trampoline use as physiotherapy for cystic fibrosis patients. Pediatr Pulmonol (2005) 1.42
Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatr (1993) 1.30
Tissue plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr (1991) 1.26
Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology (1991) 1.23
Nebulized albuterol in acute bronchiolitis. J Pediatr (1990) 1.23
Nasal potential difference measurements in patients with atypical cystic fibrosis. Eur Respir J (2001) 1.19
Osteomyelitis in fractured sternum after cardiopulmonary resuscitation. N Engl J Med (1979) 1.14
Clinical-physiologic correlations in acute asthma of childhood. Pediatrics (1991) 1.08
Coexistence of celiac disease and eosinophilic gastroenteropathy. J Pediatr Gastroenterol Nutr (2001) 1.08
Effect of vascular endothelial growth factor on hepatic regenerative activity following partial hepatectomy in rats. J Hepatol (1999) 1.07
Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients. Lancet (1990) 1.03
The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutation. Genomics (1998) 1.02
Pellagra as the presenting manifestation of Crohn's disease. Gastroenterology (1982) 1.01
Ecbalium elaterium (squirting cucumber)--remedy or poison? J Toxicol Clin Toxicol (2000) 1.00
Macular cherry-red spot, corneal clouding, and beta-galactosidase deficiency. Clinical, biochemical, and electron microscopic study of a new autosomal recessive storage disease. Arch Intern Med (1971) 0.97
Clinical implication of lung fluid balance in the perinatal period. J Perinatol (2011) 0.95
Clinical and genetic risk factors for cystic fibrosis-related liver disease. Pediatrics (1999) 0.94
Cholestatic jaundice caused by D-penicillamine. Ann Rheum Dis (1978) 0.93
Human monoclonal anti-La antibodies. The La protein resides on a subset of Ro particles. J Immunol (1989) 0.93
Growth hormone-stimulated insulin-like growth factor (IGF) I and IGF-binding protein-3 in liver cirrhosis. J Hepatol (1997) 0.92
Prognostic value of generation of growth hormone-stimulated insulin-like growth factor-I (IGF-I) and its binding protein-3 in patients with compensated and decompensated liver cirrhosis. Dig Dis Sci (1998) 0.92
Efficacy of adding nebulized ipratropium bromide to nebulized albuterol therapy in acute bronchiolitis. Pediatrics (1992) 0.92
Guillain-Barré syndrome; association with mumps. N Y State J Med (1981) 0.91
The new technology of combined transmission and emission tomography in evaluation of endocrine neoplasms. J Nucl Med (2001) 0.90
Meso-2,3-dimercaptosuccinic acid in the diagnosis and treatment of lead poisoning. J Toxicol Clin Toxicol (1987) 0.90
Correlation of HBV DNA and monoclonal reactivity to HBsAg in serum of patients with HBV infection. J Virol Methods (1986) 0.90
Night blindness and liver cirrhosis as late complications of jejunoileal bypass surgery for morbid obesity. Isr J Med Sci (1984) 0.89
Upper airway obstruction as a presenting sign of achalasia in childhood. Acta Paediatr (2000) 0.89
The effects of subcutaneous deferoxamine administration on renal function in thalassemia major. Int J Hematol (1991) 0.86
Diffuse alveolar hemorrhage following thrombolytic therapy for acute myocardial infarction. Respiration (2000) 0.86
A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations. Am J Respir Crit Care Med (1997) 0.85
Comparison of the pharmacokinetics of 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in healthy volunteers, with and without co-administration of ferrous sulfate, to thalassemia patients. Int J Clin Pharmacol Ther Toxicol (1993) 0.84
[Hyperbaric oxygen for neuropsychiatric sequelae of carbon monoxide poisoning]. Harefuah (1992) 0.84
Resolution of severe bronchiectasis after removal of long-standing retained foreign body. Pediatr Pulmonol (1998) 0.83
Basic fibroblast growth factor is hepatotropic for rat liver in regeneration. J Hepatol (1995) 0.83
Incidence of bacteraemia following fibreoptic bronchoscopy. Eur Respir J (1999) 0.82
Radiological findings of early invasive pulmonary aspergillosis in immune-compromised patients. Hematol Oncol (2009) 0.82
Anasarca and hypertrophic cardiomyopathy in a liver transplant patient on FK506: relieved after a switch to Neoral. Transplant Proc (1996) 0.82
Renal handling of cisplatin: interactions with organic anions and cations in the dog. Clin Invest Med (1991) 0.82
Bronchiolitis obliterans organizing pneumonia. Diagnosis by transbronchial biopsy. Chest (1993) 0.82
Cholestatic jaundice caused by cloxacillin: macrophage inhibition factor test in preventing rechallenge with hepatotoxic drugs. Br Med J (1980) 0.82
[Pyridoxine for severe metabolic acidosis and seizures due to isoniazid overdose]. Harefuah (1993) 0.82
CT scout view as an essential part of CT reading. Australas Radiol (2007) 0.82
Systemic inflammatory mediators and cystic fibrosis genotype. Clin Exp Med (2004) 0.81
Ultrastructure of cytoplasmic hyaline inclusions in a case of human hepatocarcinoma. Gastroenterology (1973) 0.81
Severe pulmonary disease in association with Crohn's disease in a 13-year-old girl. Pediatr Pulmonol (2000) 0.81
Wheezing in infants with cystic fibrosis: clinical course, pulmonary function, and survival analysis. Pediatrics (1992) 0.80
Determination of urinary hippuric acid in toluene abuse. J Toxicol Clin Toxicol (2001) 0.80
Low-dose vasopressin restores diuresis both in patients with hepatorenal syndrome and in anuric patients with end-stage heart failure. J Intern Med (1999) 0.80
Sequential pulmonary function measurements during treatment of infantile chronic interstitial pneumonitis. J Pediatr (1990) 0.80
Monoarthritis with heterophil-negative infectious mononucleosis. Case of an older patient. Arch Intern Med (1980) 0.80
Two cases of renal mucormycosis in renal transplanted patients. Clin Nephrol (2002) 0.80
The efficacy of calcium gluconate in ocular hydrofluoric acid burns. Hum Exp Toxicol (1997) 0.80
Seronegative polyarthritis as severe systemic disease. Neth J Med (2010) 0.79
Salivary profile and oxidative stress in children and adolescents with cystic fibrosis. J Oral Pathol Med (2009) 0.79
Severe minocycline-induced eosinophilic pneumonia: extrapulmonary manifestations and the use of in vitro immunoassays. Ann Pharmacother (1997) 0.79
Effect of endogenous digoxin-like substances on the interpretation of high concentrations of digoxin in children. J Pediatr (1990) 0.79
The efficacy of oral deferiprone in acute iron poisoning. Am J Emerg Med (2000) 0.79
Prevalence of rhinosinusitis among atypical cystic fibrosis patients. Eur Arch Otorhinolaryngol (2010) 0.79
Hepatic injury due to pyridinol carbamate. Isr J Med Sci (1978) 0.78
Oral calcium carbonate as phosphate-binder in infants and children with chronic renal failure. Miner Electrolyte Metab (1986) 0.78
Helium and oxygen treatment of severe air-diving-induced neurologic decompression sickness. Arch Neurol (1997) 0.78
Predicting the need for hospitalization in children with acute asthma. Chest (1990) 0.78
[Etiology of acute viral hepatitis in Israel]. Harefuah (1985) 0.78
Serum glucose and electrolyte levels in alcohol-intoxicated adolescents on admission to the emergency department: an unmatched case-control study. Eur J Pediatr (2012) 0.78
Antidotal therapy of severe acute organophosphate poisoning: a multihospital study. Neurotoxicol Teratol (1990) 0.77
[Hyperbaric oxygen for hydrogen sulfide poisoning]. Harefuah (1994) 0.77
A missense cystic fibrosis transmembrane conductance regulator mutation with variable phenotype. Pediatrics (1997) 0.77
The solitary pulmonary nodule: radiologic considerations. Semin Ultrasound CT MR (2000) 0.77
Microscopic nephrocalcinosis in cystic fibrosis. N Engl J Med (1989) 0.77
A pilot study on the hemodynamic effect of short-term ursodeoxycholic acid therapy in patients with stable liver cirrhosis. Am J Gastroenterol (1999) 0.77
Obstructive airway disease associated with occupational sodium hydroxide inhalation. Br J Ind Med (1992) 0.76
A high-performance liquid chromatographic method for the measurement of deferoxamine in body fluids. Ther Drug Monit (1989) 0.76
[Long-term sequelae of malignant tumors in childhood: consequences of late side-effects]. Harefuah (2001) 0.76
Nuclear magnetic resonance imaging of liver hemangiomas. J Nucl Med (1985) 0.76
Hydatid cyst of the liver rupturing into the biliary tract--mimicking acute cholecystitis on hepatobiliary scanning. Am J Gastroenterol (1985) 0.76
The significance of sweat Cl/Na ratio in patients with borderline sweat test. Pediatr Pulmonol (1995) 0.76
Pregnancy after liver transplantation. Int J Gynaecol Obstet (1993) 0.76
Hypercalciuria in chronically institutionalized bedridden children: frequency, predictive factors and response to treatment with thiazides. Int J Pediatr Nephrol (1987) 0.75
Vitiligo and primary biliary cirrhosis. Am J Gastroenterol (1984) 0.75
Autoantibodies against bactericidal/permeability-increasing protein (BPI-ANCA) in cystic fibrosis patients treated with azithromycin. Clin Exp Med (2005) 0.75
Decreased serum growth hormone-binding protein in patients with liver cirrhosis. J Clin Endocrinol Metab (1991) 0.75
First and second degree atrioventricular block in oxpentifylline overdose. Br Med J (Clin Res Ed) (1984) 0.75
[Fine needle aspiration for cytological diagnosis]. Harefuah (1977) 0.75
Retroesophageal abscess twenty-five days after esophagoscopy. An unusual complication of endoscopy. Gastrointest Endosc (1972) 0.75
[Liver damage caused by adelphan]. Schweiz Med Wochenschr (1977) 0.75
Mitochondrial pathology in the liver in a patient with the Dubin-Johnson syndrome. Isr J Med Sci (1977) 0.75
Poison exposure in children before Passover. Isr Med Assoc J (2000) 0.75
Treatment of Salmonella typhimurium salmonellosis. Lancet (1978) 0.75
[Australia antigen-positive postnecrotic cirrhosis masquerading as acute viral hepatitis]. Harefuah (1975) 0.75
[Thrombocytosis in patients with pneumonia]. Harefuah (1977) 0.75